Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Bill Requires Standard Numerical Identifiers For Drug Tracking By 2010

Executive Summary

Legislation setting specific deadlines to implement drug tracking requirements was introduced April 17 by Reps. Steve Buyer, R-Ind., and Jim Matheson, D-Utah

You may also be interested in...



Supply Chain Safety’s Dual Visions: Pedigree Or Just Serialization

As Congress considers how to ensure downstream supply chain security, industry groups are looking at a process to link drugs to their manufacturer. But in a recent communication with the Senate HELP Committee, FDA backs a “comprehensive national track-and-trace system.”

FDA To Unveil Drug Identifier System Soon, Short On Enforcement Authority

FDA is preparing to release guidance on a system for uniquely identifying units of prescription drugs

FDA To Unveil Drug Identifier System Soon, Short On Enforcement Authority

FDA is preparing to release guidance on a system for uniquely identifying units of prescription drugs

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel